Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Minden Gross LLP
Matt Maurer was quoted in "Growing like weed" on the legalization of cannabis and some of​ the difficulties that ​accompany these ​changes. The article was published on May 17, 2017 by Listed Magazine.
Gluckstein Personal Injury Lawyers
The journey to recovery for a young car accident survivor named Brianna is paved with hoofs - those of her beloved therapy horse, Ike.
Bereskin & Parr LLP
It looks like we may have a Happy Cannabis Day by July 2018.
Norton Rose Fulbright Canada LLP
The overhaul to Canada's pharmaceutical patent regime is nearly here. On May 11, 2017, the Canadian Senate passed Bill C-30 (the act intended to implement CETA into Canadian law) without amendment, the final major stage of the legislative process.
Gluckstein Personal Injury Lawyers
Dogs have a long history as man's best friend, but some are proving to be virtual life-savers for individuals with traumatic brain injury
Gluckstein Personal Injury Lawyers
With a 90% success rate, doctors may soon have at their disposal the world's most accurate technology for diagnosing concussions.
Cassels Brock
Health Canada has announced that it will require licensed cannabis producers to conduct mandatory testing of all cannabis products destined for sale for the presence of unauthorized pesticides.
Howie, Sacks & Henry
Abilify (aripiprazole) is a second-generation, atypical anti-psychotic drug known as a stabilizer. Unlike earlier anti-psychotics that simply block the brain's chemical receptors to dopamine...
Norton Rose Fulbright Canada LLP
On April 22, 2017, the Government of Canada published draft regulations Amending the Food and Drug Regulations (Vanessa's Law) that provide details regarding the minister of health's powers...
Osler, Hoskin & Harcourt LLP
On April 13, 2017, the Government of Canada introduced Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act...
McLennan Ross LLP
On April 13, 2017 the Government of Canada introduced a bill aimed at legalizing cannabis for non-medical users.
Miller Thomson LLP
The federal government introduced the Cannabis Act (Bill C-45) on April 13, 2017 to legalize and regulate the production, distribution, sale, and possession of cannabis in Canada.
Bereskin & Parr LLP
Intellectual property strategy is fundamental to the successful development and commercialization of a personalized therapeutic and its companion diagnostic.
Norton Rose Fulbright Canada LLP
With Canada moving closer towards implementing the Comprehensive Economic and Trade Agreement (CETA), major reforms to Canada's Patent Act are coming soon, including the availability of Certificates of Supplementary Protection (CSPs): ..
Torys LLP
On April 13, the federal government released the proposed Cannabis Act (Bill C-45) to legalize the production, distribution and sale of cannabis for recreational purposes.
Clyde & Co
On April 13, 2017, the Liberal Party of Canada fulfilled a 2015 campaign promise, tabling long-awaited legislation to end Canada's prohibition on cannabis.
Norton Rose Fulbright Canada LLP
Health Canada has proposed regulations that will amend the Food and Drug Regulations to allow for importation of drugs that have not yet received regulatory approval from Health Canada.
Cox & Palmer
As the Federal Government recently introduced its legislation to legalize and regulate recreational cannabis, it is clear that legalization is now imminent.
Norton Rose Fulbright Canada LLP
E.F. was a 58 year old woman who applied to the Alberta Court of the Queen's Bench in April of 2016 seeking judicial authorization
Norton Rose Fulbright Canada LLP
In March 2017, Parliament gave third reading to Bill S-201, also known as the Genetic Non-Discrimination Act.
Latest Video
Most Popular Recent Articles
Cassels Brock
Although the United States government's attitudes toward cannabis have eased in recent years, the election of President Donald Trump has generated renewed uncertainty....
Norton Rose Fulbright Canada LLP
Global M&A activity in the biopharmaceutical industry skyrocketed in 2014 and 2015, eclipsing US$200 billion in deal value each year and prompting EY to declare such elevated activity...
McInnes Cooper
But employers need to nip cannabis in the workplace in the bud by acting now to be prepared for cannabis legalization when it happens.
Blake, Cassels & Graydon LLP
The end of 2016 brought with it some good news for the defence in respect of pharmaceutical class actions, including a successful defence verdict in the first pharmaceutical product liability common issues trial in Canada.
Blake, Cassels & Graydon LLP
The anticipated legalization of recreational cannabis in Canada by July 2018 is multi-faceted. Several areas of law will come into play, potentially impacting many types of businesses. We delve into some of these areas below.
Cassels Brock
Health Canada has announced that it will require licensed cannabis producers to conduct mandatory testing of all cannabis products destined for sale for the presence of unauthorized pesticides.
Norton Rose Fulbright Canada LLP
The Regulation respecting calls for tenders for certain medications covered by the basic prescription drug insurance plan (the Regulation) came into force on April 20, 2017, supplementing provisions in An Act respecting prescription drug insurance that were added by Bill 81.
Norton Rose Fulbright Canada LLP
In March 2017, Parliament gave third reading to Bill S-201, also known as the Genetic Non-Discrimination Act.
Aitken Klee
Apotex filed a submission with Health Canada in 1988 for approval to sell a generic version of the drug trazadone.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with